Vista Pharmaceuticals Ltd

₹ 11.7 2.91%

22 Nov - close price

About

Incorporated in 1992, Vista Pharmaceuticals Ltd does manufacturing and selling of Pharmaceutical, medical and veterinary preparations. The company also sells products to its related companies engaged in the manufacture of formulations

Key Points

Business Overview:^[1]^[2]
Company offers over-the-counter & prescription generic drug products consisting of tablets, capsules, and liquids covering various therapeutic categories. It formulates, registers, produce markets, and distributes pharmaceutical products. The company has its USFDA Approved Manufacturing Facility in India and its Marketing and Distribution Center in the USA.

Website BSE

Market Cap ₹ 45.3 Cr.
Current Price ₹ 11.7
High / Low ₹ 17.9 / 10.4
Stock P/E
Book Value ₹ 12.4
Dividend Yield 0.00 %
ROCE -8.75 %
ROE -12.8 %
Face Value ₹ 2.00

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Stock is trading at 0.94 times its book value

Cons

Company has low interest coverage ratio.
Promoter holding is low: 21.2%
Company has a low return on equity of -10.8% over last 3 years.
Company has high debtors of 515 days.
Company's cost of borrowing seems high
Promoter holding has decreased over last 3 years: -15.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	0.29	0.11	0.00	0.00	0.00	0.00	0.00	1.98	3.47	1.70	3.13	1.80	2.49
	0.59	0.27	0.32	0.20	0.15	0.33	0.21	2.90	4.64	3.44	2.87	2.58	3.32
Operating Profit	-0.30	-0.16	-0.32	-0.20	-0.15	-0.33	-0.21	-0.92	-1.17	-1.74	0.26	-0.78	-0.83
OPM %	-103.45%	-145.45%						-46.46%	-33.72%	-102.35%	8.31%	-43.33%	-33.33%
	-0.05	-0.06	0.30	0.00	0.00	0.00	0.00	0.13	0.08	0.02	0.10	0.07	0.01
Interest	0.21	0.26	0.29	0.24	0.26	0.40	0.26	0.33	0.32	0.30	0.28	0.28	0.25
Depreciation	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.17	0.18	0.18	0.18	0.18	0.18
Profit before tax	-0.71	-0.63	-0.46	-0.59	-0.56	-0.88	-0.62	-1.29	-1.59	-2.20	-0.10	-1.17	-1.25
Tax %	208.45%	1.59%	-558.70%	0.00%	-57.14%	7.95%	-51.61%	-25.58%	27.04%	-25.91%	-190.00%	-26.50%	-22.40%
	-2.19	-0.63	2.11	-0.59	-0.24	-0.96	-0.30	-0.95	-2.02	-1.63	0.09	-0.86	-0.97
EPS in Rs	-0.60	-0.17	0.57	-0.16	-0.07	-0.26	-0.08	-0.25	-0.54	-0.42	0.02	-0.22	-0.25
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
	7.47	8.30	13.75	15.38	24.18	28.92	31.07	22.76	1.27	0.39	1.00	10.12	9.12
	6.65	7.08	11.05	12.78	21.12	23.59	29.84	27.56	3.00	1.66	5.32	13.41	12.21
Operating Profit	0.82	1.22	2.70	2.60	3.06	5.33	1.23	-4.80	-1.73	-1.27	-4.32	-3.29	-3.09
OPM %	10.98%	14.70%	19.64%	16.91%	12.66%	18.43%	3.96%	-21.09%	-136.22%	-325.64%	-432.00%	-32.51%	-33.88%
	0.01	0.03	0.01	0.02	0.06	0.40	2.95	3.75	0.20	0.17	0.40	0.07	0.20
Interest	0.01	0.00	0.41	0.77	0.88	1.57	1.67	1.54	1.55	0.90	1.34	1.24	1.11
Depreciation	0.64	0.77	1.05	1.02	1.02	1.34	1.36	1.35	0.73	0.62	0.62	0.72	0.72
Profit before tax	0.18	0.48	1.25	0.83	1.22	2.82	1.15	-3.94	-3.81	-2.62	-5.88	-5.18	-4.72
Tax %	50.00%	2.08%	-8.80%	8.43%	-1.64%	22.70%	18.26%	-6.60%	-47.24%	-66.03%	-3.57%	-12.93%
	0.08	0.47	1.36	0.77	1.25	2.19	0.94	-3.68	-2.01	-0.89	-5.66	-4.51	-3.37
EPS in Rs	0.01	0.06	0.11	0.06	0.47	0.75	0.31	-1.21	-0.55	-0.24	-1.54	-1.16	-0.87
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	2%
5 Years:	-20%
3 Years:	100%
TTM:	67%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	20%

Stock Price CAGR
10 Years:	17%
5 Years:	2%
3 Years:	4%
1 Year:	-32%

Return on Equity
10 Years:	-4%
5 Years:	-10%
3 Years:	-11%
Last Year:	-13%

Balance Sheet

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	15.00	15.00	5.00	5.00	5.31	5.83	6.07	6.07	7.36	7.36	7.51	9.43	12.31
Reserves	-6.37	-5.91	5.44	6.21	11.29	26.03	29.73	23.57	25.49	28.09	23.04	26.22	35.92
	0.00	0.00	4.04	7.88	11.33	11.06	11.17	15.47	10.71	12.55	9.96	7.96	6.85
	5.82	4.97	8.30	7.29	13.69	10.08	5.79	6.01	9.05	7.59	15.52	14.37	8.56
Total Liabilities	14.45	14.06	22.78	26.38	41.62	53.00	52.76	51.12	52.61	55.59	56.03	57.98	63.64
	12.45	11.69	10.73	9.96	13.46	17.67	20.52	20.66	19.93	19.33	19.74	19.32	19.04
CWIP	0.00	0.00	0.00	0.00	1.99	7.11	8.54	8.78	9.08	9.08	9.33	9.82	9.98
Investments	0.00	0.00	0.00	0.00	0.00	0.02	0.03	0.02	0.04	0.03	0.02	0.02	0.02
	2.00	2.37	12.05	16.42	26.17	28.20	23.67	21.66	23.56	27.15	26.94	28.82	34.60
Total Assets	14.45	14.06	22.78	26.38	41.62	53.00	52.76	51.12	52.61	55.59	56.03	57.98	63.64

Cash Flows

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	0.21	-0.09	-3.53	-2.50	2.57	-4.58	3.30	0.80	-6.75	-0.99	-1.71	-4.91
	-0.11	0.01	-0.09	-0.24	-3.61	-10.61	-5.65	-1.73	-0.30	-0.01	-1.27	-0.79
	-0.10	0.00	3.63	3.07	6.36	11.22	1.43	0.28	6.96	0.94	3.11	5.59
Net Cash Flow	0.00	-0.08	0.00	0.34	5.32	-3.98	-0.92	-0.64	-0.09	-0.07	0.13	-0.11

Ratios

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	0.00	45.30	299.70	231.15	136.01	137.06	98.09	164.86	623.66	9,789.49	4,106.25	515.04
Inventory Days	106.33	51.61	10.20	96.66	184.54	249.51	161.60	147.59	4,840.00	9,203.92	990.53	278.78
Days Payable	263.43	323.11	359.43	236.24	293.13	208.80	75.56	78.67	2,555.00	5,297.43	1,007.30	304.24
Cash Conversion Cycle	-157.11	-226.21	-49.53	91.57	27.41	177.77	184.14	233.77	2,908.66	13,695.97	4,089.48	489.58
Working Capital Days	-186.16	-110.38	98.75	205.76	92.23	202.32	197.71	240.55	2,261.85	14,955.64	5,204.90	499.17
ROCE %	2.21%	5.42%	14.09%	9.53%	8.93%	12.39%	6.27%	-5.21%	-5.10%	-3.76%	-10.26%	-8.75%

Shareholding Pattern

Numbers in percentages

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	36.94%	35.44%	35.44%	35.44%	35.44%	35.44%	30.48%	29.51%	27.81%	27.81%	21.19%	21.19%
	0.12%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.03%	0.03%	0.03%	0.03%	0.02%	0.02%
	62.91%	64.52%	64.52%	64.52%	64.52%	64.52%	69.46%	70.46%	72.16%	72.16%	78.79%	78.79%
No. of Shareholders	13,004	14,380	14,700	14,689	14,912	14,796	14,648	14,250	13,908	14,015	13,882	13,913

	Mar 2016	Dec 2016	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
	26.87%	26.87%	35.56%	38.14%	38.14%	35.29%	35.44%	35.44%	27.81%	21.19%
	0.00%	0.00%	0.31%	0.30%	0.30%	0.24%	0.00%	0.00%	0.00%	0.00%
	0.06%	0.06%	0.05%	0.04%	0.04%	0.04%	0.04%	0.04%	0.03%	0.02%
	73.07%	73.07%	64.08%	61.51%	61.51%	64.43%	64.52%	64.52%	72.16%	78.79%
No. of Shareholders	10,618	10,892	11,595	11,510	11,340	11,643	14,380	14,796	14,015	13,913

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings